|
| 1 |
Use of doxorubicin-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein invasion: a prospective study
Su Jong Yu, Yun Bin Lee, Eun Ju Cho, Jeong-Hoon Lee, Hyo-Cheol Kim, Jin Wook Chung, Jung-Hwan Yoon, Yoon Jun Kim
|
|
| 2 |
Posttransplant sequential adrenal and spine metastasis of hepatocellular carcinoma responsive to combined regorafenib and radiotherapy: a case report
Jae-Yoon Kim, Nam-Joon Yi, Yoon Jun Kim, Eui Kyu Chie, Jiyoung Kim, Hyun Hwa Choi, Jaewon Lee, Sola Lee, Su Young Hong, Jeong-Moo Lee, Suk Kyun Hong, YoungRok Choi, Kwang-Woong Lee, Kyung-Suk Suh
|
|
| 3 |
Comparing efficacies of different treatment regimens in patients with hepatocellular carcinoma accompanied by portal vein tumor thrombus using network meta-analysis
Seungji Lee, Sung Kyu Song, Byungje Bae, Yongkeun Park
|
|
| 4 |
Atorvastatin inhibits the proliferation of MKN45-derived gastric cancer stem cells in a mevalonate pathway-independent manner
Ye Seul Choi, Hee Jeong Cho, Hye Jin Jung
|
|
| 5 |
Sorafenib combined with radiation therapy for advanced hepatocellular carcinoma with portal and hepatic vein invasion extending to the inferior vena cava: a complete response case according to modified RECIST criteria
Yuri Cho, Bo Hyun Kim, Tae Hyun Kim, Young Hwan Koh, Joong-Won Park
J Liver Cancer.2022;22(1):63-68. Published online 2022 February 14
DOI: http://dx.doi.org/10.17998/jlc.2022.01.18
|
|
| 6 |
A Newly Developed Pancreatic Adenocarcinoma in a Patient with Advanced Thyroid Cancer under Long-Term Sorafenib Use
Min Ji Kim, Han-Sang Baek, Sung Hak Lee, Dong-Jun Lim
|
|
| 7 |
Advanced Stage Hepatocellular Carcinoma Successfully Treated with Transarterial Radioembolization and Multi-tyrosine Kinase Inhibitor Therapy
Myung Ji Goh, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
J Liver Cancer.2020;20(2):160-166. Published online 2020 September 30
DOI: http://dx.doi.org/10.17998/jlc.20.2.160
|
|
| 8 |
Early Experience of Oncolytic Virus Injection Combined with Sorafenib in a Patient with Advanced Hepatocellular Carcinoma and Portal Vein Thrombosis
Hyun Ho Jo, Seong Joon Chun, Jeong-Ju Yoo, Min Hee Lee, Sang Gyune Kim, Young Seok Kim
J Liver Cancer.2020;20(2):177-182. Published online 2020 September 30
DOI: http://dx.doi.org/10.17998/jlc.20.2.177
|
|
| 9 |
Recurrent Coronary Artery Vasospasm in a Patient with Hepatocellular Carcinoma Treated with Sorafenib: a Case Report and Literature Review
Dae Hyun Lim, Jai Hoon Yoon, Dae Won Jun, Oh Young Lee, Byung Chul Yoon, Hang Rak Lee, Kyung Soo Kim, Ho Soon Choi
J Liver Cancer.2020;20(1):67-71. Published online 2020 March 31
DOI: http://dx.doi.org/10.17998/jlc.20.1.67
|
|
| 10 |
Nivolumab for Advanced Hepatocellular Carcinoma with Multiple Lung Metastases after Sorafenib Failure
Jaewoong Kim, Jin Won Chang, Jun Yong Park
J Liver Cancer.2020;20(1):72-77. Published online 2020 March 31
DOI: http://dx.doi.org/10.17998/jlc.20.1.72
|
|
| 11 |
Successful Sequential Therapy Involving Regorafenib after Failure of Sorafenib in a Patient with Recurrent Hepatocellular Carcinoma after Liver Transplantation
Soon Kyu Lee, Jeong Won Jang, Heechul Nam, Pil Soo Sung, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon
J Liver Cancer.2020;20(1):84-89. Published online 2020 March 31
DOI: http://dx.doi.org/10.17998/jlc.20.1.84
|
|
| 12 |
An Analysis for Survival Predictors for Patients with Hepatocellular Carcinoma Who Failed to Sorafenib Treatment in Pre-regorafenib Era
Chan Uk Lee, Young-Sun Lee, Ji Hoon Kim, Minjin Lee, Sehwa Kim, Young Kul Jung, Yeon Seok Seo, Hyung Joon Yim, Jong Eun Yeon, Kwan Soo Byun
J Liver Cancer.2019;19(2):117-127. Published online 2019 September 30
DOI: http://dx.doi.org/10.17998/jlc.19.2.117
|
|
| 13 |
Radiation-induced Myositis after Proton Beam Therapy to Huge Hepatocellular Carcinoma
Jihye Kim, Gyu Sang Yoo, Dong Hyun Sinn, Hee Chul Park, Kwang Cheol Koh
J Liver Cancer.2019;19(2):136-142. Published online 2019 September 30
DOI: http://dx.doi.org/10.17998/jlc.19.2.136
|
|
| 14 |
Sorafenib-induced Pancreatic Pseudocyst in a Patient with Advanced Hepatocellular Carcinoma: a Rare Adverse Event
Dae-ha Kim, Minkoo Kim, Hyung Joon Yim, Sang Jun Suh, Young Kul Jung
J Liver Cancer.2019;19(2):154-158. Published online 2019 September 30
DOI: http://dx.doi.org/10.17998/jlc.19.2.154
|
|
| 15 |
The Genomic Landscape and Its Clinical Implications in Hepatocellular Carcinoma
Sun Young Yim, Ju-Seog Lee
J Liver Cancer.2019;19(2):97-107. Published online 2019 September 30
DOI: http://dx.doi.org/10.17998/jlc.19.2.97
|
|
| 16 |
A Case of Achieving Partial Remission with the Combination of Sorafenib and Nivolumab in a Patient with Hepatocellular Carcinoma Showing Disease Progression after Nivolumab Therapy
Sang Youn Hwang, Seon-Mi Lee, Jung Woo Im, Ki Jeong Jeon, Cheol-Won Choi, Kyung-Su Kim, Wan Jeon
J Liver Cancer.2019;19(1):74-78. Published online 2019 March 31
DOI: http://dx.doi.org/10.17998/jlc.19.1.74
|
|
| 17 |
Comparison of Radioembolization and Sorafenib for the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Systematic Review and Meta-Analysis of Safety and Efficacy
Pyeong Hwa Kim, Sang Hyun Choi, Jin Hyoung Kim, Seong Ho Park
Korean J Radiol.2019;20(3):385-398. Published online 2019 January 30
DOI: http://dx.doi.org/10.3348/kjr.2018.0496
|
|
| 18 |
Adverse Events of Tyrosine Kinase Inhibitors in Patients with Advanced Thyroid Cancer
Min Joo Kim, Young Joo Park
|
|
| 19 |
Efficacy of Sorafenib for the Treatment of Post-Transplant Hepatocellular Carcinoma Recurrence
Seong Hee Kang, Hyeki Cho, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Yoon Jun Kim, Nam-Joon Yi, Kwang-Woong Lee, Kyung-Suk Suh, Jung-Hwan Yoon
|
|
| 20 |
Management of very late peritoneal metastasis of hepatocellular carcinoma 10 years after liver transplantation: Lessons from two cases
Abdulwahab A Alshahrani, Shin Hwang, Gi-Won Song, Deok-Bog Moon, Dong-Hwan Jung, Chul-Soo Ahn, Ki-Hun Kim, Tae-Yong Ha, Gil-Chun Park, Su-Min Ha, Yo-Han Park, Sung-Gyu Lee
|
|
